The Hormone Trap: Why Young Founders Must Avoid Clomid
Huberman Lab reveals why Fadogia Agrestis shows promise for testosterone, but warns young founders against clomiphene's long-term risks.
40 hours of podcasts, in 5 minutes.
Andrew Huberman and Dr. Kyle Gillett discuss a comprehensive approach to male hormone optimization, covering foundational lifestyle pillars, essential bloodwork, and various supplement-based tools. They also delve into the nuances of testosterone replacement therapy (TRT), warning against its use in younger men with normal levels, and explore novel applications for medications like tadalafil for prostate health and topical treatments for hair loss.
Huberman Lab reveals why Fadogia Agrestis shows promise for testosterone, but warns young founders against clomiphene's long-term risks.
Huberman Lab unpacks how low-dose tadalafil boosts prostate health and sleep. Learn to keep your hair without systemic DHT impact using topical dutasteride.
Andrew Huberman and Dr. Kyle Gillett reveal why testosterone replacement therapy (TRT) is a dangerous shortcut for young men with normal levels.